Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
ERBB family receptor tyrosine kinases are overexpressed in a significant subset of breast cancers. One of these receptors, HER2/neu, or ErbB-2, is the target for a new rational therapeutic antibody, Herceptin. Other inhibitors that target this receptor, and another family member, the epidermal growt...
Gardado en:
| Publicado en: | Breast Cancer Res |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2000
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138772/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11250707/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr51 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|